Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

7/16/25 Bicillin L-A Restriction

July 16, 2025

Pharmacist,

 

The following e-mail was just sent to the HH Medical Staff and is being distributed throughout HH:
 
Effective immediately, Penicillin G Benzathine (Bicillin® L-A) injectable suspension will be restricted at HH Main, HH W&C, and Madison Hospital to the use in patients with confirmed congenital syphilis and syphilis in pregnancy (risk of congenital syphilis) due to manufacturer recall and extremely limited supply. This has received emergency approval by the P&T Committee and the Medical Staff Office. Providers may reach out to pharmacy for alternative therapies in other indications. Pharmacy is continuing to investigate alternative products and will provide updates when available.
Let me know if you have any questions. 

 

Thanks,

 

Brian Boyett, Pharm. D.
Manager, Decentralized Pharmacy Services
Huntsville Hospital
Office: 256-265-4522






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved